FDA approves Xeris’ GVOKE injection for treatment of severe hypoglycaemia

Image: FDA grants approval for Xeris Pharmaceuticals’ GVOKE injection for treatment of severe hypoglycaemia. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.